4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000158
President and CEO sold 4,746 shares at $2.96 ($14,065)
- President and CEO acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2021-12-01 | Option exercise | +10,938 | 289,697 | D: show line 1 in the form | ||
| Brunn Carsten President and CEO | 2021-12-02 | Sale | −4,746 | $2.96 | $14,065 | 284,951 | D: show line 2 in the form |
| Open-market sales · 4,746 sh · avg $2.96 · $14,065 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2021-12-01 | Option exercise · Restricted Stock Units | −10,938 | 43,750 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_163856690437223.xml…